null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

Vanucizumab ELISA Kit (GXEL00140)

SKU GXEL00140
Product Type ELISA Kit
Assay Type Quantitative
Detection Method Colorimetric
Sensitivity 0.156 μg/ml
Range 0.31-5 μg/mL
Size 96T
Synonyms RG-7221, RG7221, RO5520985, 1448221-05-3
$1,162
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

Vanucizumab ELISA Kit

The Vanucizumab ELISA Kit (SKU: GXEL00140) is a quantitative sandwich ELISA designed for the accurate quantitative detection of Vanucizumab across Plasma, Serum. With a working range of 0.31-5 μg/mL and a sensitivity of 0.156 μg/ml, the kit combines a simple protocol with dependable colorimetric read-out for confident quantification.

Vanucizumab (RG7221) is an experimental humanized monoclonal antibody (mAb) designed for the treatment of cancer. Vanucizumab is a bi-specific mAb composed of two different heavy chains and two different light chains. One arm of the antibody binds Angiopoietin-2 (Ang2) and the other is based on bevacizumab (Avastin), binding vascular endothelial growth factor A (VEGF-A). The antibody is designed to inhibit both VEGF-A and Ang2 simultaneously to offer superior clinical benefit compared to VEGF-A inhibition alone. This drug was developed by Genentech/Roche. On 12 Mar 2018, Roche completes a phase I trial in solid tumors (combination therapy, late-stage disease, metastatic disease, second-line therapy or greater) in Spain, France, and Belgium.

Backed by Assay Genie quality control and technical support, this Vanucizumab ELISA Kit is an ideal tool for laboratories studying Vanucizumab. Order the Vanucizumab ELISA Kit from Assay Genie for dependable performance.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose